Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

AbCellera Biologics Inc (ABCL) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
1 hour ago
Danny Green
Neutral
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...

Market News
1 hour ago
Stuart Mooney
Bullish
news icon
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...

Market News
1 hour ago
Andrew Wynn
Bearish
news icon
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Trading in all issues of GoldCoast Resource Corp. (symbol GCR) has resumed at 8:00 AM ET following a temporary halt imposed by the Canadian Investment Regulatory Organization (CIRO). Such halts are used to maintain fair and orderly markets. CIRO over...

Market News
2 hours ago
Na
Neutral
Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Equity Bancshares director Leon Borck increased his stake by purchasing 380 shares at $48.78 each, signaling confidence after the company reported strong Q3 results. The bank posted a net income of $26.8 million and core earnings of $1.40 per diluted...

Market News
2 hours ago
Alex Lavoie
Bullish
news icon
Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...

Market News
3 hours ago
Globe Newswire
Neutral
Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

Netflix film chief Dan Lin exits amid major executive shakeup and layoffs

Netflix's film chief Dan Lin is leaving just before Peter Rice takes over as chief content officer on October 26, following a broad executive overhaul that included the departure of content boss Bela Bajaria and layoffs of about 1,000 employees. Lin,...

Market News
4 hours ago
New York Post
Bearish
news icon
Netflix film chief Dan Lin exits amid major executive shakeup and layoffs

1987 crash lesson: recent AI stock sell-off may not reflect company health, says Jim Cramer

Jim Cramer draws a parallel between the 1987 stock market crash and the recent sell-off in AI-related stocks, emphasizing that falling share prices don't always indicate problems with the companies themselves. The 1987 crash involved automatic sellin...

Market News
4 hours ago
CNBC
Neutral
1987 crash lesson: recent AI stock sell-off may not reflect company health, says Jim Cramer

FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...

Market News
4 hours ago
Anaptysbio, Inc.
Bullish
news icon
FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

Microsoft launches Guardian Agents to monitor and secure AI agents in enterprises.

Microsoft introduced Guardian Agents, a new security feature to monitor AI agents within enterprises, addressing risks from AI acting unpredictably or as insider threats. This is part of Project Perception, which aims to separate control of AI intell...

Market News
4 hours ago
TechCrunch
Bullish
news icon
Microsoft launches Guardian Agents to monitor and secure AI agents in enterprises.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $3.82B
  • Volume
    4,112,108
  • Sector
    Health
  • 52W High
    $14.82
  • 52W Low
    $2.78
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $3.42B
  • Div Yield
    -
  • Trading Activity
    100% Sell | 0% Buy
$11.9
52W Low: $2.78
05 Feb 2026
52W High: $14.82
29 Sep 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $14.82, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!